ABSTRACT

In this chapter, we discuss some of the situations in which an asthmatic patient may require different management to usual treatment has been discussed in previous chapters. It is important to recognize these special situations in the asthmatic patient, because if we do so may be serious complications and unnecessary in its evolution. Although the list can be quite extensive, this section will refer to asthma during natural hormonal changes like pregnancy or the menstrual cycle, the relationship with intolerance to NSAIDs, care needs asthmatic patients before and after surgery, and ultimately the patient who is facing an event of anaphylaxis.

KEYWORDS

Anaphylaxis, asthma, aspirin, surgery, pregnancy, menstruation.

REFERENCES

1. Schatz M. Inter-relationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol 1999; 103(2 Pt 2): S330-6.

2. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998; 158(4): 1091-5.

3. Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 2005; 25(4): 731-50.

4. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment- 2004 update. J Allergy Clin Immunol 2005; 115(1): 34-46.

5. Jeon YH, Yang HJ, Pyun BY. Lung function in Korean adolescent girls: in association with obesity and the menstrual cycle. J Korean Med Sci 2009; 24(1): 20-5.

6. Murphy VE, Gibson PG. Premenstrual asthma: prevalence, cycle-to-cycle variability and relationship to oral contraceptive use and menstrual symptoms. J Asthma 2008; 45(8): 696-704.

7. Drosdzol A, Skrzypulec V, Wilk K, Rachel M. The influence of bronchial asthma on menstrual cycle. J Physiol Pharmacol 2007; 58 (Suppl 5): 165-73.

8. Pasaoglu G, Mungan D, Abadoglu O, Misirligil Z. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma? J Asthma 2008; 45(2): 95-9.

9. Oh SH, Patterson R. Surgery in corticosteroid-dependent asthmatics. J Allergy Clin Immunol 1974; 53(6): 345-51.

10. GINA 2008. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. 2008. Disponible en: http://www.ginasthma.com

11. Harding SM. Acid reflux and asthma. Curr Opin Pulm Med 2003; 9(1): 42-5.

12. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2000; 2.

13. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111(5): 913-21.

14. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16(3): 432-6.

15. Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004; 10(1): 51-6.

16. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104(1): 5-13.

17. Dahlen SE, Malmstrom K, Nizankowska E, Dahlen B, Kuna P, Kowalski M, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, doubleblind, placebo-controlled trial. Am J Respir Crit Care Med 2002; 165(1): 9-14.

18. The diagnosis and management of anaphylaxis. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol 1998; 101(6 Pt 2): S465-528.

19. NAEPP-EP3 2007. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute, 2007.